211
Active Trials
71
Phase 1
46
Phase 2
91
Phase 3
14
Therapeutic Areas
Portfolio Concentration: 52% of active trials in Oncology
Oncology
109 active / 229 total
Solid Tumor (Advanced)
31 active
6 Ph3
64 total since 2015
NSCLC
16 active
5 Ph3
34 total since 2015
Breast Cancer
7 active
2 Ph3
17 total since 2015
Non-Hodgkin Lymphoma
7 active
10 total since 2015
Prostate Cancer
5 active
2 Ph3
8 total since 2015
Pancreatic Cancer
4 active
9 total since 2015
Sarcoma
3 active
12 total since 2015
Colorectal Cancer
3 active
8 total since 2015
Cholangiocarcinoma
3 active
6 total since 2015
Triple Negative Breast Cancer
3 active
5 total since 2015
Hematologic Malignancies
3 active
4 total since 2015
CLL
3 active
3 total since 2015
Thyroid Cancer
3 active
3 total since 2015
Ovarian Cancer
2 active
4 total since 2015
Cervical Cancer
2 active
3 total since 2015
Head and Neck Cancer
2 active
3 total since 2015
Bladder Cancer
2 active
3 total since 2015
Brain Tumor
2 active
2 total since 2015
Esophageal Cancer
2 active
2 total since 2015
SCLC
1 active
4 total since 2015
ALL
1 active
3 total since 2015
Multiple Myeloma
1 active
1 total since 2015
AML
1 active
1 total since 2015
MDS
1 active
1 total since 2015
Endometrial Cancer
1 active
1 total since 2015
Gastric Cancer
0 active
8 total since 2015
Hepatocellular Carcinoma
0 active
4 total since 2015
Melanoma
0 active
3 total since 2015
Neuroendocrine Tumors
0 active
1 total since 2015
Renal Cell Carcinoma
0 active
1 total since 2015
Hodgkin Lymphoma
0 active
1 total since 2015
Metabolic
78 active / 256 total
Immunology
68 active / 171 total
Ankylosing Spondylitis
29 active
18 Ph3
54 total since 2015
Rheumatoid Arthritis
10 active
5 Ph3
22 total since 2015
Ulcerative Colitis
8 active
5 Ph3
16 total since 2015
Crohn's Disease
6 active
4 Ph3
8 total since 2015
Atopic Dermatitis
5 active
4 Ph3
29 total since 2015
Lupus
4 active
3 Ph3
11 total since 2015
Psoriatic Arthritis
3 active
2 Ph3
6 total since 2015
Psoriasis
2 active
1 Ph3
24 total since 2015
IBD
1 active
1 Ph3
1 total since 2015
CNS
23 active / 63 total
Alzheimer's Disease
10 active
7 Ph3
24 total since 2015
Alcohol Use Disorder
3 active
2 Ph3
3 total since 2015
Migraine
2 active
2 Ph3
26 total since 2015
Parkinson's Disease
1 active
2 total since 2015
Neuropathy
1 active
2 total since 2015
Schizophrenia
1 active
1 total since 2015
Bipolar Disorder
1 active
1 total since 2015
ALS
1 active
1 total since 2015
Opioid Use Disorder
1 active
1 total since 2015
Major Depression
1 active
1 Ph3
1 total since 2015
Multiple Sclerosis
1 active
1 total since 2015
Cardiovascular
8 active / 18 total
Urology
6 active / 7 total
Pain
5 active / 14 total
Renal
5 active / 9 total
Musculoskeletal
4 active / 16 total
Respiratory
2 active / 3 total
Rare Disease
2 active / 3 total
Gastrointestinal
2 active / 2 total
Dermatology
1 active / 3 total
Infectious Disease
0 active / 8 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)